project id: TCGA-LIHC; case submitter id: TCGA-2Y-A9HA; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.89; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.61; rna integrity number: 9.2; age at index: 70; days to birth: -25892; days to death: 36; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1942; year of death: 2012; age at diagnosis: 25892; ajcc pathologic m: MX; ajcc pathologic n: NX; ajcc pathologic stage: Stage II; ajcc pathologic t: T2; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C22.0; last known disease status: not reported; morphology: 8170/3; primary diagnosis: Hepatocellular carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Liver; synchronous malignancy: No; tissue or organ of origin: Liver; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; weight: 30.0; composition: Not Reported; days to collection: 713; days to sample procurement: 0; initial weight: 90.0; portion submitter id: TCGA-2Y-A9HA-01A-11; percent lymphocyte infiltration: 4.0; percent monocyte infiltration: 0.0; percent necrosis: 3.0; percent neutrophil infiltration: 1.0; percent normal cells: 0.0; percent stromal cells: 8.0; percent tumor cells: 89.0; percent tumor nuclei: 95.0;